Look for:

Products

JOHNSON & JOHNSON


ISIN:
US4781601046
WKN:
478160104

2024/03/28 19:25:10
Price
158.415 USD
Difference 0.29% (0.46)

General attributes

ISINUS4781601046
SymbolJNJ
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)351,693 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)158.41 USD (300)
Ask (Ask size)158.42 USD (100)
Open158.20 USD
High159.14 USD
Low158.11 USD
Close (prev. day)157.96 USD
VWAP158.482666 USD
Volume (pcs)2,127,334
Trading volume337,150,849.24
Number of trades55,718
Last size400

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: JOHNSON & JOHNSONPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 19:25:10
Price
158.415 USD
Difference 0.29% (0.46)

General attributes

ISINUS4781601046
SymbolJNJ
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)351,693 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)158.41 USD (300)
Ask (Ask size)158.42 USD (100)
Open158.20 USD
High159.14 USD
Low158.11 USD
Close (prev. day)157.96 USD
VWAP158.482666 USD
Volume (pcs)2,127,334
Trading volume337,150,849.24
Number of trades55,718
Last size400

Performance and Risk

6m1Y3Y
Perf (%)+0.54%+3.04%-4.23%
Perf (abs.)+0.85+4.66-6.97
Beta0.360.230.31
Volatility13.2915.7315.86
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)155.986 USD (7,197,640)
Ø price 30 days | Ø volume 30 days (pcs.)158.817 USD (7,251,573)
Ø price 100 days | Ø volume 100 days (pcs.)156.799 USD (7,026,201)
Ø price 250 days | Ø volume 250 days (pcs.)159.689 USD (10,934,302)
YTD High | date163.580 USD (2024/01/22)
YTD Low | date154.760 USD (2024/03/26)
52 Weeks High | date175.970 USD (2023/08/10)
52 Weeks Low | date144.950 USD (2023/10/27)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/03/2817:35146.50 EUR0.3885
Vienna Stock Exchange2024/03/2817:32146.50 EUR0.002
Tradegate2024/03/2819:15146.80 EUR1.07186
Stuttgart2024/03/2819:11146.90 EUR0.1613
SIX Swiss Exchange2023/05/2517:36136.00 USD0.001
SIX Swiss Exchange2023/03/0117:36500.00 CHF0.001
NYSE2024/03/2819:25158.415 USD337.1855,725
Munich2024/03/2815:15146.60 EUR0.002
London Stock Exchange2024/03/2817:35158.50 USD0.0214
Hanover2024/03/2808:10145.70 EUR0.001
Hamburg2024/03/2818:15146.90 EUR0.002
Frankfurt2024/03/2819:05146.60 EUR0.0812
Euronext Milan MTF Trading After Hours2024/03/1818:33145.40 EUR0.011
Euronext Milan MTF Global Equity Market2024/03/2817:44146.60 EUR0.001
Duesseldorf2024/03/2816:30146.60 EUR0.004
Berlin2024/03/2808:01145.90 EUR0.001
BX Swiss2024/03/2818:00143.006 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2419&ID_TYPE_IMAGE_LOGO=2

Contact Details

JOHNSON & JOHNSON
- -
One Johnson & Johnson Plaza - 08933 New Brunswick
Telefon: +1-732-524-0400
Fax: +
E-mail: -

PDF Downloads

Company report: JOHNSON & JOHNSONPDF Download

Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Members of Management Board

Jennifer DoudnaMember of Board of Directors
Mark McClellanMember of Board of Directors
Mary BeckerleMember of Board of Directors
Nadja WestMember of Board of Directors
Paula JohnsonMember of Board of Directors
Anne MulcahyMember of Board of Directors
D. DavisMember of Board of Directors
Darius AdamczykMember of Board of Directors
Eugene WoodsMember of Board of Directors
Hubert JolyMember of Board of Directors
Marillyn HewsonMember of Board of Directors
Mark WeinbergerMember of Board of Directors
Joaquin DuatoChairman of Managing Board
Mathai MammenMember of Executive Committee
Peter M. FasoloMember of Executive Committee
William N. HaitMember of Executive Committee
Ashley McEvoyMember of Executive Committee
James SwansonMember of Executive Committee
Jennifer TaubertMember of Executive Committee
Joseph WolkMember of Executive Committee
Kathryn E. WengelMember of Executive Committee
Michael H. UllmannMember of Executive Committee
Thibaut MongonMember of Executive Committee
Vanessa BroadhurstMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.